Matthew Hawryluk
Director/Board Member presso PREDICTIVE ONCOLOGY INC.
Patrimonio netto: 761 476 $ in data 31/03/2024
Profilo
Matthew J.
Hawryluk is an Independent Director at Predictive Oncology, Inc. and the Chief Business Officer & Executive Vice President at Gritstone bio, Inc. He was previously the Vice President-Corporate & Business Development at Foundation Medicine, Inc. Hawryluk received his undergraduate degree from the University of Notre Dame, his MBA from the Tepper School of Business, and his doctorate from the University of Pittsburgh School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GRITSTONE BIO, INC.
0.29% | 01/02/2024 | 286 880 ( 0.29% ) | 737 282 $ | 31/03/2024 |
PREDICTIVE ONCOLOGY INC
0.23% | 05/04/2024 | 9 488 ( 0.23% ) | 24 194 $ | 31/03/2024 |
Posizioni attive di Matthew Hawryluk
| Società | Posizione | Inizio |
|---|---|---|
| GRITSTONE BIO, INC. | Corporate Officer/Principal | 01/11/2015 |
| PREDICTIVE ONCOLOGY INC. | Director/Board Member | 29/11/2022 |
Precedenti posizioni note di Matthew Hawryluk
| Società | Posizione | Fine |
|---|---|---|
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | - |
Formazione di Matthew Hawryluk
| University of Notre Dame | Undergraduate Degree |
| Tepper School of Business | Masters Business Admin |
| University of Pittsburgh School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| GRITSTONE BIO, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
- Borsa valori
- Insiders
- Matthew Hawryluk
